Angiodynamics (ANGO) Cash from Operations (2010 - 2026)

Angiodynamics' Cash from Operations history runs 17 years deep, the most recent figure standing at 17452000.0 for Q2 2026.

• Quarterly Cash from Operations fell 7.22% year-over-year to 17452000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was 3089000.0 (up 130.5% YoY) and the FY2026 annual result came in at 3089000.0, up 130.5% from the prior year.
• Cash from Operations was 17452000.0 for Q2 2026 at Angiodynamics, up from 3110000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 18811000.0 in Q2 2025 and bottomed at 25899000.0 in Q3 2023.
• A 5-year average of 1963888.89 and a median of 1921500.0 in 2023 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations surged 286.35% — and 2024, when it plunged 1014.31%.
• Angiodynamics' Cash from Operations stood at 7499000.0 in 2022, then decreased by 29.78% to 5266000.0 in 2023, then slumped by 53.04% to 2473000.0 in 2024, then jumped by 88.48% to 4661000.0 in 2025, then surged by 274.43% to 17452000.0 in 2026.
• Business Quant data shows ANGO's Cash from Operations at 17452000.0 in Q2 2026, 3110000.0 in Q1 2026, and 4661000.0 in Q4 2025.